Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001427570-17-000018
Filing Date
2017-11-03
Accepted
2017-11-03 08:51:33
Documents
63
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q obln-93017x10q.htm 10-Q 1021548
2 EXHIBIT 31.1 obln311.htm EX-31.1 12393
3 EXHIBIT 31.2 obln312.htm EX-31.2 12388
4 EXHIBIT 32.1 obln321.htm EX-32.1 8574
  Complete submission text file 0001427570-17-000018.txt   4604969

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT obln-20170930.xml EX-101.INS 841209
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT obln-20170930.xsd EX-101.SCH 35504
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT obln-20170930_cal.xml EX-101.CAL 72040
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT obln-20170930_def.xml EX-101.DEF 136920
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT obln-20170930_lab.xml EX-101.LAB 500599
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT obln-20170930_pre.xml EX-101.PRE 284994
Mailing Address 5421 AVENIDA ENCINAS SUITE F San Diego CA 92008
Business Address 5421 AVENIDA ENCINAS SUITE F San Diego CA 92008 858-480-2400
OBALON THERAPEUTICS INC (Filer) CIK: 0001427570 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37897 | Film No.: 171174746
SIC: 3841 Surgical & Medical Instruments & Apparatus